

Stock image for referential purposes only
AnorTech Inc. has announced a one-year research collaboration with the National Research Council of Canada (NRC) to develop alumina-based catalysts for carbon dioxide (CO2) capture using the company's sustainable alumina.
{alcircleadd}The collaboration follows testing carried out in 2025, during which AnorTech supplied several grades of alumina to the NRC for use in catalysts designed to capture CO2 and convert it into methane through a hydrogenation process.
The alumina samples were produced from material sourced from AnorTech's Gronne Bjerg anorthosite project in Greenland and processed at the Lakefield laboratory of SGS Canada Inc.
Under the agreement, AnorTech will jointly fund the project and provide all alumina samples required for the research programme.
Over the next 12 months, NRC researchers will work on developing and optimising amine-functionalised alumina adsorbents for CO2 capture. The research will focus on improving adsorption capacity, selectivity and long-term stability.
Testing will be conducted under different operating conditions, including varying temperatures, CO2 concentrations, humidity levels and simulated flue gas environments.
Commenting on the collaboration, Jim Cambon, President of AnorTech, said, "We are very excited to partner with Canada’s research and innovation organisation."
To know the long-term bauxite market forecast, book our report: “Global Bauxite & Alumina Market Forecast to 2036: Supply–Demand, Trade Flows & Price Outlook”
AnorTech owns the Gronne Bjerg anorthosite project in Greenland, located about 80 kilometres northeast of Nuuk. In 2025, the company filed a provisional patent application in the United States covering its sustainable alumina production process. It also shipped 15 tonnes of anorthosite from the Gronne Bjerg project to Ontario for pilot-scale testing.
The company reported working capital of approximately USD 1.6 million. It also expects to receive USD 1 million and Greenland Mines' Nasdaq-listed shares valued at approximately USD 750,000 following the completion of the transfer of the Sarfartoq rare earth element (REE) licence.
AnorTech currently has a market capitalisation of about USD 10.4 million. The company has generated a 167 per cent return over the past year, although it remains unprofitable.
Responses







